» Articles » PMID: 10400417

Interleukin-11 (IL-11) Enhances Clonal Proliferation of Acute Myelogenous Leukemia Cells with Strong Expression of the IL-11 Receptor Alpha Chain and Signal Transducing Gp130

Overview
Journal Leukemia
Specialties Hematology
Oncology
Date 1999 Jul 10
PMID 10400417
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

We examined the effect of recombinant human interleukin (IL)-11 alone or in combination with various colony-stimulating factors (CSFs), including IL-3, granulocyte/macrophage (GM)-CSF, granulocyte (G)-CSF, stem cell factor (SCF), flt3 ligand (FL), and thrombopoietin (TPO), on colony formation by leukemic progenitor cells (L-CFU) obtained from 33 patients with acute myelogenous leukemia (AML). Leukemic colony formation was found in approximately 70 to 80% of the patients in the presence of at least one of the above CSFs. Although IL-11 alone did not support L-CFU, the growth of these progenitors in the presence of other cytokines was enhanced by IL-11 in 16 out of 33 patients and it showed a synergistic action with G-CSF in 12 of them. This synergistic action occurred in seven out of nine M5 patients (French-American-British (FAB) classification). A single cell clone-sorting experiment clearly demonstrated that this synergistic effect was operative at the single progenitor cell level. The number of leukemic cells proliferating in the presence of G-CSF+IL-11 was significantly higher than in the presence of G-CSF alone, suggesting that IL-11 recruited dormant leukemic progenitors into the cell cycle. Flow cytometric analysis revealed that all types of AML blast cells (M0 approximately M6) ubiquitously expressed gp130, although the level of expression was significantly higher in M5 cells. In contrast, expression of the IL-11 receptor alpha chain (IL-11Ralpha) varied between FAB types. Blast cells obtained from M1, M3 and M5 patients showed higher levels of expression, with M5 cells showing the strongest expression. Interestingly, the leukemic progenitor cells for which proliferation was synergistically enhanced by IL-11 had significantly higher expression of both IL-11Ralpha and gp130. These results suggest that administration of IL-11 in vivo may stimulate the proliferation of leukemic progenitor cells, particularly M5 cells, in the presence of G-CSF, and that the responsiveness of L-CFU to IL-11 may be predicted by a simple receptor assay.

Citing Articles

Targeting IL11 Receptor in Leukemia and Lymphoma: A Functional Ligand-Directed Study and Hematopathology Analysis of Patient-Derived Specimens.

Karjalainen K, Jaalouk D, Bueso-Ramos C, Bover L, Sun Y, Kuniyasu A Clin Cancer Res. 2015; 21(13):3041-51.

PMID: 25779950 PMC: 4490100. DOI: 10.1158/1078-0432.CCR-13-3059.


A multicenter randomized, double-blind, placebo-controlled late-phase II/III study of recombinant human interleukin 11 in acute myelogenous leukemia.

Usuki K, Urabe A, Ikeda Y, Ohashi Y, Mizoguchi H, Takaku F Int J Hematol. 2007; 85(1):59-69.

PMID: 17261503 DOI: 10.1532/IJH97.06027.


Molecular analysis of signaling events mediated by the cytoplasmic domain of leukemia inhibitory factor receptor alpha subunit.

Liu H, Liu S, Tang S, Ji K, Wang F, Hu S Mol Cell Biochem. 2004; 258(1-2):15-23.

PMID: 15030166 DOI: 10.1023/b:mcbi.0000012829.10405.e1.